45 CFR § 180 compliance
B · 85
This hospital published most of what § 180 requires.
●Machine-readable file published
●Gross / standard charges
●Discounted cash price
●Payer-specific negotiated rates
○Min / max negotiated charges
●Free, public, no login required
Procedures listed
14,320
Insurances with rates
3
CPT / HCPCS codes
14,131
Source MRF
Most expensive procedures (gross)
| Code | Description | Gross | Cash | Min payer | Max payer | # insurers |
|---|---|---|---|---|---|---|
| J0225 | VUTRISIRAN 25 MG/0.5 ML SUBCUTANEOUS SYRINGE | $482,413 | $337,689 | — | — | 5 |
| J0202 | ALEMTUZUMAB 12 MG/1.2 ML INTRAVENOUS SOLUTION | $243,806 | $170,664 | — | — | 5 |
| J2351 | OCRELIZUMAB 920 MG-HYALURONIDASE-OCSQ 23,000 UNIT/23 ML SUBCUT SOLN | $174,344 | $122,041 | — | — | 5 |
| L8699 | HC TAG TBE AORTIC COMPONENT 12MM X 45MM X 15CM | $140,480 | $98,336 | — | — | 5 |
| C1882 | HC ICD DEFIB UNIFY CRT CD3231-40Q | $137,992 | $96,594 | — | — | 5 |
| J3590 | DEPEMOKIMAB-ULAA 100 MG/ML SUBCUTANEOUS SYRINGE | $130,832 | $91,582 | — | — | 5 |
| J2507 | PEGLOTICASE 8 MG/ML INTRAVENOUS SOLUTION | $128,487 | $89,941 | — | — | 5 |
| J9298 | NIVOLUMAB 240 MG-RELATLIMAB-RMBW 80 MG/20 ML INTRAVENOUS SOLUTION | $125,638 | $87,947 | — | — | 5 |
| C1822 | PULSE GENERATOR IMPLANTABLE 301328 | $122,838 | $85,987 | — | — | 4 |
| A9543 | HC NM YTTRUIM 90 ZEV TO 40MCI | $119,876 | $83,913 | — | — | 5 |
| C1721 | HC ICD DEFIB FORTIFY DR 2231-40Q | $114,900 | $80,430 | — | — | 5 |
| C1824 | HC GENERATR OPTIMIZER SMART MINI CCM | $114,087 | $79,861 | — | — | 5 |
| J9266 | PEGASPARGASE 750 UNIT/ML INJECTION SOLUTION | $108,327 | $75,829 | — | — | 5 |
| Q0480 | PR DRIVER PNEUMATIC VAD, REP | $107,626 | $75,338 | — | — | 2 |
| C1820 | GENERATOR PULSE RESTORE SENSOR SURE SCAN 29408 | $106,992 | $74,894 | — | — | 5 |
| J9229 | INOTUZUMAB OZOGAMICIN 0.9 MG(0.25 MG/ML INITIAL CONCENTRATION) IV SOLN | $96,756 | $67,729 | — | — | 5 |
| C2624 | HC SENSOR CARDIOMEMS PA | $96,719 | $67,703 | — | — | 5 |
| J0638 | CANAKINUMAB (PF) 150 MG/ML SUBCUTANEOUS SOLUTION | $89,539 | $62,678 | — | — | 5 |
| J2350 | OCRELIZUMAB 30 MG/ML INTRAVENOUS SOLUTION | $86,126 | $60,288 | — | — | 5 |
| J9316 | PERTUZUMAB 1,200 MG-TRASTUZUMAB 600 MG-HYALURON-ZZXF/15 ML SUBCUT SOLN | $84,069 | $58,848 | — | — | 5 |
| J9022 | ATEZOLIZUMAB 1,200 MG/20 ML (60 MG/ML) INTRAVENOUS SOLUTION | $83,347 | $58,343 | — | — | 5 |
| J9309 | POLATUZUMAB VEDOTIN-PIIQ 140 MG INTRAVENOUS SOLUTION | $78,248 | $54,774 | — | — | 5 |
| 33249 | HC INSRT PACE DEFIB W LEAD | $77,023 | $53,916 | — | — | 5 |
| C1875 | HC STENT GRAFT RELAYPRO THORACIC 200MM | $76,808 | $53,765 | — | — | 5 |
| J3241 | TEPROTUMUMAB-TRBW 500 MG INTRAVENOUS SOLUTION | $74,256 | $51,979 | — | — | 5 |
| 93656 | HC TX ATRIAL FIB PULM VEIN ISOL | $68,983 | $48,288 | — | — | 5 |
| J9334 | EFGARTIGIMOD ALFA 1008 MG-HYALURON-QVFC 11,200 UNIT/5.6 ML SUBCUT SOLN | $65,879 | $46,115 | — | — | 5 |
| 33263 | HC REMV REPLC CVD GEN DUAL LEAD | $65,333 | $45,733 | — | — | 5 |
| 33270 | HC INSERT/REPLACE SUBSEQ DEFIBRILLATOR | $64,170 | $44,919 | — | — | 5 |
| C1767 | INTERSTIM INS 16370 | $62,955 | $44,069 | — | — | 5 |
| J9144 | DARATUMUMAB 1,800 MG-HYALURONIDASE-FIHJ 30,000 UNIT/15 ML SUBCUT SOLN | $60,808 | $42,566 | — | — | 5 |
| 33262 | HC REMV REPLAC CVD GEN SINGLE LEAD | $60,618 | $42,432 | — | — | 5 |
| J9043 | CABAZITAXEL 10 MG/ML (FIRST DILUTION) INTRAVENOUS SOLUTION | $58,908 | $41,236 | — | — | 5 |
| 37231 | PR REVSC OPN/PRQ TIB/PERO W/STNT/ATHR/ANGIOP SM VSL | $58,333 | $40,833 | — | — | 4 |
| C1772 | PUMP SYNCHROMED II 40MM 16566 | $57,953 | $40,567 | — | — | 5 |
| C1722 | HC INTICA NEO 7 VR-T DX DF-1 PROMRI | $57,926 | $40,548 | — | — | 5 |
| 33264 | HC REMV REPLC CVD GEN MULT LEAD | $57,711 | $40,398 | — | — | 5 |
| 93654 | HC EP & ABLATE VENTRIC TACHY | $57,380 | $40,166 | — | — | 5 |
| C9363 | MESH BILAYER WOUND MATRIX SZ 4 X 5 INTEGRA 106616 | $55,986 | $39,190 | — | — | 4 |
| A9543 | PR Y90 IBRITUMOMAB, RX | $52,935 | $37,055 | — | — | 2 |
| J9042 | BRENTUXIMAB VEDOTIN 50 MG INTRAVENOUS SOLUTION | $52,237 | $36,566 | — | — | 5 |
| J2327 | RISANKIZUMAB-RZAA 60 MG/ML INTRAVENOUS SOLUTION | $51,513 | $36,059 | — | — | 5 |
| C1768 | HC EXCLUDER CONFORM AAA TRUNK-IPSILTRL LEG | $51,037 | $35,726 | — | — | 5 |
| 93653 | HC EP & ABLATE SUPRAVENT ARRHYT | $50,759 | $35,531 | — | — | 5 |
| C9767 | HC REVASC LOW EXT LITHOTRIP-STENT-ATHER INCL ANGIOPL | $49,502 | $34,651 | — | — | 5 |
| A9545 | PR I131 TOSITUMOMAB, RX | $48,836 | $34,186 | — | — | 2 |
| J9272 | DOSTARLIMAB-GXLY 50 MG/ML INTRAVENOUS SOLUTION | $48,670 | $34,069 | — | — | 5 |
| J9271 | PEMBROLIZUMAB 25 MG/ML INTRAVENOUS SOLUTION | $47,720 | $33,404 | — | — | 15 |
| J2329 | UBLITUXIMAB-XIIY 25 MG/ML INTRAVENOUS SOLUTION | $46,930 | $32,851 | — | — | 5 |
| C1831 | HC STABLE-L INTERBODY 30X28X12 | $46,910 | $32,837 | — | — | 5 |
Showing top 50 of 14,320 priced procedures, sorted by gross charge.
Data straight from this hospital's federally-mandated machine-readable file (45 CFR § 180). The compliance grade reflects how completely the hospital published the six required data elements, not the quality of care.